Alzheimer’s drug bapineuzumab shelved after trial failure

US pharmaceutical companies Pfizer and Johnson & Johnson say they will stop development of Alzheimer’s drug bapineuzumab, because it failed in two late-stage clinical trials. Bapineuzumab, made by Pfizer and Johnson & Johnson, was designed to halt build-up of plaque in the brain. But it failed to improve cognitive or functional performance compared with a [...]





























